October 14, 2025
In the News
Kyle Faget on FDA UDI Guidance – 'Industry has called for clarification'
Foley & Lardner LLP partner Kyle Faget weighed in on the U.S. Food and Drug Administration's guidance on Unique Device Identifier (UDI) requirements for combination medical devices in the Medical Device Network article, "FDA’s UDI guidance ‘ambiguity’ could lead to inconsistent implementation."